Consequences of the COVID-19 Pandemic: Reduced Hemoglobin A1c Diabetes Monitoring.
Consequences of the COVID-19 Pandemic: Reduced Hemoglobin A1c Diabetes Monitoring.
复制标题
DOI：
10.1089/pop.2020.0134
复制
发表时间：
2021-03
影响因子：
2.5
通讯作者：
McPhaul MJ
中科院分区：
文献类型：
--
作者：
Fragala MS;Kaufman HW;Meigs JB;Niles JK;McPhaul MJ
指南支持的糖尿病管理包括定期监测糖化血红蛋白（HbA 1c），建议每年检测2至4次。由于日常社交或不寻常的社会环境（例如与COVID-19疫情相关的居家令）而中断HbA 1c检测可能会影响糖尿病管理。我们检查了COVID-19疫情居家令期间（2020年3月和4月）一家大型国家实验室的每周HbA 1c检测量，以检验疫情导致HbA 1c监测减少的假设。将2020年3月1日开始的每周检测量与前60周（2019年1月6日至2020年2月29日）190万糖尿病患者（定义为2017年1型或2型糖尿病的ICD-10代码，2018年至少进行2次HbA 1c检测）的平均每周检测量进行比较。这项Quest Diagnostics Health Trends™研究被西方机构审查委员会视为豁免。
Guidelines-supported management of diabetes includes regular monitoring of glycated hemoglobin (HbA1c) with recommended testing frequencies of 2 to 4 times per year. Interruptions in HbA1c testing because of daily social or unusual societal circumstances, such as the stay-at-home orders associated with the COVID-19 pandemic, may impair diabetes management.We examined weekly HbA1c test volumes at a large national laboratory during the COVID-19 pandemic stay-at-home orders (in March and April 2020) to test the hypothesis that the pandemic has led to decreased HbA1c monitoring. Weekly test volumes beginning March 1, 2020 were compared to mean weekly test volumes in the previous 60 weeks (January 6, 2019–February 29, 2020) in 1.9 million patients with diabetes (defined as having an ICD-10 code for type 1 or 2 diabetes in 2017 and with at least 2 HbA1c tests in 2018). This Quest Diagnostics Health Trends™ study was deemed exempt by the Western Institutional Review Board.
登录
查看更多内容
影响因子：
105.7
作者：
Stratton, IM;Adler, AI;Holman, RR
通讯作者：
Holman, RR
影响因子：
--
作者：
Fitch, Kathryn;Pyenson, Bruce S.;Iwasaki, Kosuke
通讯作者：
Iwasaki, Kosuke
影响因子：
5.7
作者：
Samuels, T. Alafia;Bolen, Shari;Brancati, Frederick L.
通讯作者：
Brancati, Frederick L.
影响因子：
3
作者：
Karter, AJ;Parker, MM;Selby, JV
通讯作者：
Selby, JV
影响因子：
16.2
作者：
Gilmer, TP;O'Connor, PJ;Solberg, LI
通讯作者：
Solberg, LI